tiprankstipranks

Andrew T. Kaplan Insider Profile

4 Followers
Andrew T. Kaplan, Director, Ten Percent Owner at Kailera Therapeutics, Inc., holds 26.26M shares in Kailera Therapeutics, Inc. (Ticker: KLRA), holds 49.95M shares in Surgery Partners (Ticker: SGRY).
tipranks
Andrew T. Kaplan

Andrew T. Kaplan
Kailera Therapeutics, Inc. (KLRA)
Director, Ten Percent Owner

Ranked #53,644 out of 108,921 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+0.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1B
64.41%
35.59%
A breakdown of Andrew T. Kaplan's holdings

Insider Roles

Surgery Partners
(SGRY)
Director, Ten Percent Owner
Kailera Therapeutics, Inc.
(KLRA)
Director, Ten Percent Owner
Roles that Andrew T. Kaplan holds in companies

Most Profitable Insider Trade

Stock:
Surgery Partners
(SGRY)
Rating:Informative Sell
Date:Dec 21, 2023 - Dec 21, 2024
Return:+35.80%
The most profitable trade made by Andrew T. Kaplan

Andrew T. Kaplan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Kailera Therapeutics, Inc.
Apr 20, 2026
Director, Ten Percent Owner
Uninformative Buy
$389.63M
Surgery Partners
Dec 21, 2023
Director, Ten Percent Owner
Uninformative Sell
$705.25M
List of latest transactions for each holding click on a transaction to see Andrew T. Kaplan's performance on stock

Andrew T. Kaplan insider profile FAQ

What is the percentage of profitable transactions made by Andrew T. Kaplan?
The percentage of profitable transactions made by Andrew T. Kaplan is 50%.
    What is the average return per transaction made by Andrew T. Kaplan?
    The average return per transaction made by Andrew T. Kaplan is 0.90%.
      What stocks does Andrew T. Kaplan hold?
      Andrew T. Kaplan holds: KLRA, SGRY stocks.
        What was Andrew T. Kaplan’s latest transaction?
        Andrew T. Kaplan latest transaction was an Uninformative Buy of ―.
          What was Andrew T. Kaplan's most profitable transaction?
          Andrew T. Kaplan’s most profitable transaction was an Informative Sell of SGRY stock on December 21, 2023. The return on the trade was 35.80%.
            What is Andrew T. Kaplan's role in Kailera Therapeutics, Inc.?
            Andrew T. Kaplan's role in Kailera Therapeutics, Inc. is Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.